Website maintenance took place on Thursday 30 April 2026. If you experience any issues, please contact us.
AusPAR: Vaxelis
Device/Product Name
Vaxelis
Active ingredients
Diphtheria, tetanus, pertussis (acellular, component), hepatitis B (rDNA), poliovirus (inactivated) and haemophilus influenzae type b conjugate vaccine (adsorbed)
AusPAR Date
Published
Sponsor
Submission Number
PM-2021-01695-1-2
Submission Type
New biological medicine
Decision
Approved